
    
      In Period 1, subjects will receive a single oral dose of 25 mg IPI-145, followed by a
      15-minute IV infusion of approximately 2.8 Î¼g 14C-IPI-145 containing 14.8 kBq of
      radioactivity.

      In Period 2, the same subjects will receive a single dose of 25 mg 14C-IPI-145 as an oral
      suspension, containing approximately 3.15 MBq of radioactivity.

      There will be a washout period of at least 14 days between Period 1 and Period 2.
    
  